Teligent Stock Forecast, Price & News

+0.01 (+2.79 %)
(As of 09/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume2.72 million shs
Average Volume4.29 million shs
Market Capitalization$34.16 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for Teligent and its competitors with MarketBeat's FREE daily newsletter.

Teligent logo

About Teligent

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.99 out of 5 stars

Medical Sector

1231st out of 1,352 stocks

Pharmaceutical Preparations Industry

602nd out of 665 stocks

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Teligent (NASDAQ:TLGT) Frequently Asked Questions

What stocks does MarketBeat like better than Teligent?

Wall Street analysts have given Teligent a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teligent wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teligent?

Teligent saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,470,000 shares, a decrease of 33.5% from the August 15th total of 2,210,000 shares. Based on an average daily volume of 3,250,000 shares, the short-interest ratio is currently 0.5 days. Approximately 1.6% of the company's shares are sold short.
View Teligent's Short Interest

When is Teligent's next earnings date?

Teligent is scheduled to release its next quarterly earnings announcement on Thursday, December 30th 2021.
View our earnings forecast for Teligent

How were Teligent's earnings last quarter?

Teligent, Inc. (NASDAQ:TLGT) released its earnings results on Monday, August, 16th. The company reported ($0.14) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.01.
View Teligent's earnings history

How has Teligent's stock been impacted by Coronavirus (COVID-19)?

Teligent's stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLGT shares have decreased by 88.7% and is now trading at $0.3680.
View which stocks have been most impacted by COVID-19

When did Teligent's stock split? How did Teligent's stock split work?

Teligent's stock reverse split on the morning of Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

Who are Teligent's key executives?

Teligent's management team includes the following people:
  • Timothy B. Sawyer, President, Chief Executive Officer & Director
  • Antonio di Nicola, Vice President-Operations & General Manager
  • Ernest R. de Paolantonio, Chief Financial Officer
  • Devendra Shah, Vice President-Research & Development
  • Philip K. Yachmetz, Secretary, Chief Legal Officer & Executive VP

What is Tim Sawyer's approval rating as Teligent's CEO?

2 employees have rated Teligent CEO Tim Sawyer on Tim Sawyer has an approval rating of 100% among Teligent's employees. This puts Tim Sawyer in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), AbbVie (ABBV), General Electric (GE), Biocept (BIOC), Lannett (LCI), Pfizer (PFE), Selecta Biosciences (SELB) and VBI Vaccines (VBIV).

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Who are Teligent's major shareholders?

Teligent's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Silverback Asset Management LLC (3.79%), Nantahala Capital Management LLC (2.61%), Vanguard Group Inc. (0.99%), Geode Capital Management LLC (0.61%), Renaissance Technologies LLC (0.33%) and Citadel Advisors LLC (0.33%). Company insiders that own Teligent stock include R Carter Pate and Sciences Opportunities Fu Life.
View institutional ownership trends for Teligent

Which major investors are selling Teligent stock?

TLGT stock was sold by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, Silverback Asset Management LLC, Renaissance Technologies LLC, and Virtu Financial LLC.
View insider buying and selling activity for Teligent
or view top insider-selling stocks.

Which major investors are buying Teligent stock?

TLGT stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Geode Capital Management LLC, Citadel Advisors LLC, Millennium Management LLC, Morgan Stanley, Morgan Stanley, and Northern Trust Corp.
View insider buying and selling activity for Teligent
or or view top insider-buying stocks.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.37.

How much money does Teligent make?

Teligent has a market capitalization of $34.16 million and generates $45.31 million in revenue each year.

How many employees does Teligent have?

Teligent employs 2,357 workers across the globe.

What is Teligent's official website?

The official website for Teligent is

Where are Teligent's headquarters?

Teligent is headquartered at 105 LINCOLN AVENUE, BUENA NJ, 08310.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at (856) 697-1441 or via email at [email protected].

This page was last updated on 9/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.